Literature DB >> 17186753

The use of digital video recorders (DVRs) for capturing digital video files for use in both The Observer and Ethovision.

J S Church1, D G Martz, N J Cook.   

Abstract

Before switching a laboratory from analog to digital, for the recording of video files for use in Noldus software such as Ethovision and The Observer, researchers need to proceed with caution. There are obvious advantages in moving to digital recording for behavioral work, including increased storage capacity; no requirement to purchase video tapes; immediate search by date, time, or event; digital images are of higher quality; ability to view study sites remotely by Internet connection; and "smart" features, such as motion detection. But before you throw away your time-lapse video recorders, time code generators, and video multiplexors, there are some important cautions to take account of. Some research groups have bought digital surveillance systems on the assumption that they work with Ethovision and The Observer, only to be disappointed. The vast majority of systems depend on proprietary compression software that must then be converted to work properly in Ethovision or The Observer.

Mesh:

Year:  2006        PMID: 17186753     DOI: 10.3758/bf03192797

Source DB:  PubMed          Journal:  Behav Res Methods        ISSN: 1554-351X


  3 in total

1.  Caging of planktonic rotifers in microfluidic environment for sub-lethal aquatic toxicity tests.

Authors:  Rhys Cartlidge; Donald Wlodkowic
Journal:  Biomicrofluidics       Date:  2018-08-03       Impact factor: 2.800

Review 2.  Towards High-Throughput Chemobehavioural Phenomics in Neuropsychiatric Drug Discovery.

Authors:  Jason Henry; Donald Wlodkowic
Journal:  Mar Drugs       Date:  2019-06-06       Impact factor: 5.118

3.  IRC-082451, a novel multitargeting molecule, reduces L-DOPA-induced dyskinesias in MPTP Parkinsonian primates.

Authors:  Romina Aron Badin; Brigitte Spinnewyn; Marie-Claude Gaillard; Caroline Jan; Carole Malgorn; Nadja Van Camp; Frédéric Dollé; Martine Guillermier; Sabrina Boulet; Anne Bertrand; Marc Savasta; Michel Auguet; Emmanuel Brouillet; Pierre-Etienne Chabrier; Philippe Hantraye
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.